Swiss-American multinational pharmaceutical corporation
USFDA gives nod to Novartis’ therapy for rare cancer among children: The study reported a safety profile consistent with the adult population studied in NETTER-1 ...
financialexpress.com/healthcare/pharma-healthcare/usfda-gives-nod-to-novartis-therapy-for-rare-cancer-among-children/3468162/
Do babies have autism because their mothers took a Novartis drug? - Zofinger Tagblatt
zofingertagblatt.ch/klage-in-den-usa-asthma-mittel-von-novartis-sollte-schwangeren-bei-vorzeitigen-wehen-helfen-doch-hat-es-bei-babys-autismus-ausgeloest/
Novartis begins tender offer for cancer-focused MorphoSys: Novartis said on Thursday it has launched a tender offer to acquire MorphoSys ...
reuters.com/business/healthcare-pharmaceuticals/novartis-begins-tender-offer-morphosys-2024-04-11/
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Novartis enters into licensing deal for Arvinas’ cancer drug worth up to $1.01 billion
financialexpress.com/healthcare/pharma-healthcare/novartis-enters-into-licensing-deal-for-arvinas-cancer-drug-worth-up-to-1-01-billion/3454058/
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Novartis Seeks Malaria Patients in New Places as Climate Shifts: Malaria season should be over in Burkina Faso and Mali. This year, that’s not the case ...
bloomberg.com/news/articles/2024-04-04/novartis-seeks-malaria-patients-in-new-places-as-climate-shifts
Paid articlePaid
Novartis acquires German biotech MorphoSys for CHF2.5 billion: Even after its numerous acquisitions in 2023, the pharmaceutical company Novartis has not yet ...
swissinfo.ch/eng/business/novartis-acquires-german-biotech-morphosys-for-chf2_5-billion/49189882
3 Top Stocks to Watch From the Best International Money Managers: Managers of highly rated funds own these foreign stocks. Should you?
morningstar.com/stocks/3-top-stocks-watch-best-international-money-managers-2
Biotech company: Federal Cartel Office approves takeover of Morphosys: The pharmaceutical giant Novartis announced its purchase of the German biotech company for ...
handelsblatt.com/unternehmen/industrie/biotechfirma-bundeskartellamt-gibt-uebernahme-von-morphosys-frei/100023231.html
In Memorium: Ranjit Shahani: Ranjit Shahani aged 73 passed away on March 9. Industry and well-wishers mourn his sad demise.
financialexpress.com/healthcare/in-memorium-ranjit-shahani/3420412/
New kebab and pizza takeaway plans refused for Houghton's Newbottle Street over obesity concerns
sunderlandecho.com/news/politics/council/new-kebab-and-pizza-takeaway-plans-refused-for-houghtons-newbottle-street-over-obesity-concerns-4539747
Paid articlePaid
Man to spend life in prison for killing TikTok personality and his date at California movie theater
nbcnews.com/news/us-news/man-spend-life-prison-killing-tiktok-personality-date-california-movie-rcna140598
Novartis inaugurates new premises in Egypt, reinforcing commitment to patients and healthcare system
Read more: bitly.ws/3eCFz
Novartis makes progress with myeloid leukaemia drug: Swiss pharma Novartis sees clinical trial superiority of Scemblix for Philadelphia chromosome-positive ...
swissinfo.ch/eng/sci-tech/novartis-makes-progress-with-myeloid-leukaemia-drug/49109142
Novartis announces strategic review of Novartis India Limited: Drug major Novartis AG on Friday announced a strategic review of Novartis India Ltd ...
business-standard.com/companies/news/drug-major-novartis-ag-announces-a-strategic-review-of-india-unit-124021601190_1.html
CML: 'You have to educate yourself so that you can be your own advocate'
cmladvocates.net/2023/12/11/you-have-to-educate-yourself-so-that-you-can-be-your-own-advocate/
Top pharma CEO says preparedness for a new pandemic has not improved: Vas Narasimhan, CEO of Novartis, told CNBC that he didn't believe there had been much ...
cnbc.com/2024/01/17/novartis-ceo-says-preparedness-for-a-new-pandemic-has-not-improved.html
Novartis Sees Strong Profit Growth Amid Demand For New Drugs: Novartis AG forecast earnings will grow at a high single digit pace this year as the Swiss ...
bloomberg.com/news/articles/2024-01-31/novartis-sees-strong-profit-growth-amid-demand-for-new-drugs
Paid articlePaid
WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics: Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug.
wsj.com/business/deals/novartis-in-advanced-talks-to-buy-cytokinetics-d1032569
Popular weight loss injections: Eli Lilly and Novo Nordisk are chasing records: Investors expect record-high sales from new therapies to treat obesity. However ...
nzz.ch/wirtschaft/beliebte-abnehmspritzen-eli-lilly-und-novo-nordisk-jagen-rekorde-ld.1773336
If you can't build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
cnbc.com/2023/12/13/where-ma-could-be-heading-in-the-obesity-drug-space.html
Paid articlePaid US FDA investigating safety risk of CAR-T cancer therapies: The U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies ...
reuters.com/legal/government/us-fda-investigating-safety-risk-car-t-cancer-therapies-2023-11-28/
Bradley Lowery: Sheffield Wednesday fan sentenced over photo jibe: Dale Houghton is given a 12-week suspended jail term for mocking the young Sunderland fan's ...
bbc.com/news/uk-england-south-yorkshire-67444742
Corona theater shooter claims voices prompted him to kill 2 teens: Joseph Jimenez testified Monday in his insanity trial that will send him either to prison or a ...
pressenterprise.com/2023/12/04/corona-theater-shooter-claims-voices-prompted-him-to-kill-2-teens/
Novartis Lifts Outlook After Shedding Sandoz Generics Unit: Novartis AG raised its profit forecast for a third time in the drugmaker’s first report after ...
bloomberg.com/news/articles/2023-10-24/novartis-lifts-outlook-after-shedding-sandoz-generics-unit
Bradley Lowery: Man pleads guilty to public order offence after mocking death of six-year-old football mascot
news.sky.com/story/bradley-lowery-man-pleads-guilty-to-public-order-offence-after-mocking-death-of-six-year-old-football-mascot-12974786
Quick Glance: Man convicted for mocking deceased football mascot
- A 31-year-old man has been convicted for mocking the death of football mascot Bradley Lowery at a match.
- A participant held up an image of Bradley, who passed away at the age of six due to neuroblastoma.
- A statement was read out in court by Gemma Lowery, Bradley's mother.
- Following the incident, over £11,000 has been raised for The Bradley Lowery Foundation, a charity established after the boy's death.
UK's Syncona writes off 54.5 mln stg after Novartis ends Gyroscope's therapy: British healthcare investment firm Syncona (SYNCS.L) said on Monday Novartis (NOVN ...
reuters.com/business/healthcare-pharmaceuticals/uks-syncona-writes-off-545-mln-stg-after-novartis-ends-gyroscopes-therapy-2023-09-11/
Sandoz owners are banking on margin cure: Sandoz’s (SDZ.S) investors are giving CEO Richard Saynor the benefit of the doubt. Shares in the generics drug maker ...
reuters.com/breakingviews/sandoz-owners-are-banking-margin-cure-2023-10-04/
Quick Glance: Novartis' Sandoz spin-off's market debut valued in billions
- A sign identifies Novartis' Cambridge facility
- Sandoz (SDZ.S) opened at 24 Swiss francs ($26.05) on Wednesday, valuing the generic and biosimilar drugmaker at 10.3 billion francs on its first day of trading.
Obesity: expectations for Novo Nordisk are enormous: The Danish company Novo Nordisk is highly regarded among investors. Only it has so far managed to launch new ...
nzz.ch/wirtschaft/fettleibigkeit-die-erwartungen-an-novo-nordisk-sind-enorm-ld.1754791
Quick Glance: Weight Loss Injections: The New Billion-Dollar Formula of the Pharmaceutical Industry
- Camilla Sylvest oversees trading strategy at Novo Nordisk
- Wegovy reduces risk of strokes and heart attacks in overweight individuals
- Mechanism of Wegovy in reducing heart attacks and strokes still unclear
- Novo Nordisk ranks in lower middle of pharmaceutical industry based on revenue
WSJ News Exclusive | How Novartis’s CEO Learned From His Mistakes and Got Help From an Unlikely Quarter
wsj.com/health/pharma/how-novartiss-ceo-learned-from-his-mistakes-and-got-help-from-an-unlikely-quarter-b087ebbb
Novartis plans Sandoz spin-off around Oct. 4, proposes share distribution: Novartis (NOVN.S) on Friday proposed to offer shareholders one Sandoz share for every ...
reuters.com/business/healthcare-pharmaceuticals/novartis-plans-sandoz-spin-off-around-oct-4-proposes-share-distribution-2023-08-18/
Novartis withdraws capmatinib from the market, only stock clearance: Berlin - The MET inhibitor capmatinib (Tabrecta) will no longer be sold by Novartis in ...
aerzteblatt.de/nachrichten/145942/Novartis-nimmt-Capmatinib-vom-Markt-nur-noch-Lagerabverkauf
After the pandemic: investors take a critical view of Lonza: Drug maker Lonza has unexpectedly lost momentum in the first half of the year. Nevertheless ...
nzz.ch/wirtschaft/lonza-ld.1748140
This biotech stock is a cancer-fighting 'powerhouse' with nearly 50% upside, says Jefferies
cnbc.com/2023/08/17/this-cancer-fighting-biotech-stock-has-nearly-50percent-upside-says-jefferies.html
Paid articlePaid Sandoz completes acquisition of Astellas’ antifungal agent, strengthens its global anti-infectives portfolio
financialexpress.com/healthcare/pharma-healthcare/sandoz-completes-acquisition-of-astellas-antifungal-agent-strengthens-its-global-anti-infectives-portfolio/3224787/
The PTAheute weekly quiz: How do migraine headaches usually occur? What is Adeps solidus and what does “Triple Whammy” stand for? We test your specialist ...
ptaheute.de/aktuelles/2022/06/07/das-ptaheute-wochenquiz
Home office conflict: desire and reality are far apart.: Employees would rather work at home. But bosses want them back in the office more - because productivity ...
tagesanzeiger.ch/homeoffice-konflikt-wunsch-und-realitaet-klaffen-weit-auseinander-774259445348
Paid articlePaid Sandoz gets USFDA approval for its biosimilar to treat relapsing forms of multiple sclerosis
financialexpress.com/healthcare/pharma-healthcare/sandoz-gets-usfda-approval-for-its-biosimilar-to-treat-relapsing-forms-of-multiple-sclerosis/3222574/
After the pandemic: investors take a critical view of Lonza: Drug maker Lonza has unexpectedly lost momentum in the first half of the year. Nevertheless ...
nzz.ch/wirtschaft/lonza-ld.1748140
General practitioners in England advise practices against the cholesterol-lowering drug inclisiran
aerzteblatt.de/nachrichten/145265/Hausaerzte-in-England-raten-Praxen-vom-Cholesterinsenker-Inclisiran-ab
That's how ill Germany's students are: Head- and back pain, concentration and sleep problems - Significantly more students are reporting this today than in 2015 ...
zm-online.de/news/detail/so-krank-sind-deutschlands-studierende
Novartis share buyback: Pharma giant's new program shows drugs could be cheaper: The drug company is swimming in money and launches a new $15 billion share ...
tagesanzeiger.ch/das-handeln-von-novartis-zeigt-medikamente-koennten-guenstiger-sein-624362781855
To transform, the Irish health service must adopt more of a leadership and innovation mindset
irishtimes.com/sponsored/2023/04/19/to-transform-the-irish-health-service-must-adopt-more-of-a-leadership-and-innovation-mindset/
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
cnbc.com/2023/05/28/asco-will-focus-on-the-cancer-fight-these-stocks-are-in-the-spotlight.html
Paid articlePaid Sandoz to exclusively commercialise six products from key therapeutic areas in United States
financialexpress.com/healthcare/pharma-healthcare/sandoz-to-exclusively-commercialise-six-product-from-key-therapeutic-areas-in-united-states/3073872/
Amgen sues Sandoz to block generic version of bone cancer and osteoporosis drugs: Reportedly, Novartis which is also named in this complaint is preparing to spin ...
financialexpress.com/healthcare/pharma-healthcare/amgen-sues-sandoz-to-block-generic-version-of-bone-cancer-and-osteoporosis-drugs/3072497/
Commentary: Singapore cannot rely only on crowdfunding to help those with rare diseases
channelnewsasia.com/commentary/singapore-healthcare-expensive-gene-therapy-zolgensma-rare-disease-3494681
Evotec and Novartis collaborate: Hamburg - The pharmaceutical researcher Evotec from Hamburg is cooperating with the Swiss pharmaceutical company Novartis ...
aerzteblatt.de/nachrichten/143069/Evotec-und-Novartis-arbeiten-zusammen
Rupert Murdoch testified that Fox News hosts ‘endorsed’ stolen election narrative
theguardian.com/media/2023/feb/27/rupert-murdoch-deposition-dominion-lawsuit-fox-news
‘No further hope’ for Tom Sizemore after brain aneurysm, actor’s family says: A representative for the Saving Private Ryan and Heat actor confirmed his family is ...
theguardian.com/film/2023/feb/28/no-further-hope-for-tom-sizemore-after-brain-aneurysm-actors-family-says
Seven healthy habits may help cut dementia risk, study says: Researchers present initial findings from study that followed thousands of US women for about 20 ...
theguardian.com/society/2023/feb/27/seven-healthy-habits-may-help-cut-dementia-risk-study-says
What Happens When You Delete All Your Emails: A sense of panic set in when I realized I’d erased the entirety of my inbox.
theatlantic.com/ideas/archive/2022/11/deleted-emails-gmail-inbox-capacity/672244/
Doctor with Stage 4 cancer is refused access to lifesaving treatment on the NHS: Dr Asha Umrawsingh, 50, was first diagnosed with breast cancer in 2010
independent.co.uk/news/uk/home-news/breast-cancer-symptoms-stage-four-treatment-b2290854.html
USFDA approves Novartis’ combination targeted therapy for pediatric brain cancer: These data were highlighted as part of an official press briefing and oral ...
financialexpress.com/healthcare/pharma-healthcare/usfda-approves-novartis-combination-targeted-therapy-for-pediatric-brain-cancer/3012897/
Doctors Worry About Shortage of Pluvicto Medication for Prostate Cancer Patients: Novartis AG is trying to boost the availability of life-extending treatment ...
techtimes.com/articles/289056/20230316/doctors-worry about-shortage-pluvicto-medication for-prostate-cancer-patients.htm
Adderall, Oxycodone Access to be Tightened Under Proposed Rules: US regulators are proposing limits on telehealth prescriptions of certain medications to combat ...
bloomberg.com/news/articles/2023-02-25/us-cut-patients-telehealth-prescriptions-battle-opioid-addiction
Top pharma CEO says Covid likely to become endemic, urges investment in pandemic preparedness
cnbc.com/2023/01/19/novartis-ceo-says-covid-to-become-endemic-calls-for-better-pandemic-preparedness.html
'Ask before assisting' and more tips to create a more tolerable world for people with disabilities
news24.com/life/wellness/body/ask-before-assisting-and-more-tips-to-create-a-more-tolerable-world-for-people-with-disabilities-20230113-2
Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again: Lower-priced competitors could take away nearly a quarter of industry sales
wsj.com/articles/pfizer-novartis-merck-executives-say-they-are-hunting-for-deals-again-11675907783
Paid articlePaid USFDA accepts Sandoz’ Biologics License Application for proposed osteoporosis drug biosimilar
financialexpress.com/healthcare/pharma-healthcare/usfda-accepts-sandoz-biologics-license-application-for-proposed-osteoporosis-drug-biosimilar/2972565/
Novartis CEO interview on layoffs, future of pharma giant: Vasant Narasimhan, the CEO of Novartis, told Insider he expected to cut the pharma giant's headcount ...
businessinsider.com/novartis-ceo-interview-on-layoffs-future-of-pharma-giant-2023-1
Paid articlePaid Novartis’ investigational drug shows positive outcomes in patients with rare blood disorder
financialexpress.com/healthcare/pharma-healthcare/novartis-investigational-drug-shows-positive-outcomes-in-patients-with-rare-blood-disorder/2905916/
EU approves treatment for prostate cancer: The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis ...
news.abs-cbn.com/overseas/12/13/22/eu-approves-treatment-for-prostate-cancer
Swiss pharma giants fall in access to medicine ranking: Both Roche and Novartis have slipped in a ranking of the top 20 pharma companies’ efforts to expand ...
swissinfo.ch/eng/business/swiss-pharma-giants-fall-in-access-to-medicine-ranking/48059014
Pandemic: Novartis boss sees trend towards normalization: The loss of several thousand jobs weighs on the profitability of the pharmaceutical company Novartis ...
nzz.ch/wirtschaft/der-chef-von-novartis-ist-fuer-das-eigene-geschaeft-und-die-entwicklung-der-pandemie-zuversichtlich-ld.1708895
Knells Country House 'disappointed' to receive 'requires improvement': A CARLISLE care home has said they are 'disappointed' after a report from a healthcare ...
newsandstar.co.uk/news/23129558.knells-country-house-disappointed-receive-requires-improvement/
Green Acres caravan park in Houghton crowned best in the Northwest: A caravan park in Cumbria has been named the best in the Northwest of England.
newsandstar.co.uk/news/23116461.green-acres-caravan-park-houghton-crowned-best-northwest/
Biontech Acquires Novartis Facility in Singapore: Mainz - The Mainz-based pharmaceutical company Biontech is taking over a production plant from the Swiss group ...
aerzteblatt.de/nachrichten/138819/Biontech-uebernimmt-Anlage-von-Novartis-in-Singapur
Novartis’ prostate cancer drug shows positive results in trial; Gets EMA recommendation
financialexpress.com/healthcare/pharma-healthcare/novartis-prostate-cancer-drug-shows-positive-results-in-trial-gets-ema-recommendation/2712112/
Day 4 of the Hindustan Times Leadership Summit 2022 begins with Novartis CEO Vas Narasimhan who speaks about his vision for modern science and medicine in ... Show more
#EnvisioningANewTomorrow
First-ever licensing deal struck for cancer drug: Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukemia treatment ...
english.alarabiya.net/News/world/2022/10/20/First-ever-licensing-deal-struck-for-cancer-drug
Novartis feels the strong dollar: Basel - The result of the pharmaceutical company Novartis was also affected by the strength of the dollar in the third quarter ...
aerzteblatt.de/nachrichten/138379/Novartis-spuert-den-starken-Dollar
How can we deliver sustainable healthcare? 3 industry leaders lay out solutions: Three industry leaders tackling the massive challenge of delivering sustainable ...
weforum.org/agenda/2022/09/3-industry-leaders-lay-out-solutions-to-better-protect-global-health-systems/
Novartis says lung cancer drug canakinumab fails another trial: Novartis (NOVN.S) said on Monday its canakinumab drug to help treat non-small cell lung cancer ...
reuters.com/business/healthcare-pharmaceuticals/novartis-says-lung-cancer-drug-canakinumab-failed-phase-iii-trial-2022-08-15/
Novartis reports Zolgensma caused two deaths from liver failure: Novartis AG (NOVN.S) on Thursday reported two patient fatalities due to acute liver failure ...
reuters.com/business/healthcare-pharmaceuticals/novartis-reports-zolgensma-caused-two-deaths-liver-failure-2022-08-11/
Novartis to invest $ 300 million in early technical development capabilities for biotherapeutics
financialexpress.com/healthcare/news-healthcare/novartis-to-invest-300-million-in-early-technical-development-capabilities-for-biotherapeutics/2664848/
Quick Glance: Novartis invests $300 million in biotherapeutics development
- Novartis is creating a fully integrated, dedicated scientific environment with a budget of $300 million to enhance capacity and capabilities for early technical development of biologics.
- This investment supports the goal of accelerating and prioritizing development across the global portfolio.
- Novartis' early-stage biologics portfolio has grown significantly in the last 15 years.
- The investment positions Novartis at the forefront of biotherapeutic development with advanced technical infrastructure and high-level capabilities.
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics